- Home
- TBBK vs JANX Comparison
TBBK vs JANX Comparison
Compare TBBK & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBK
- JANX
- Stock Information
- Founded
- TBBK 1999
- JANX 2017
- Country
- TBBK United States
- JANX United States
- Employees
- TBBK N/A
- JANX N/A
- Industry
- TBBK Major Banks
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- TBBK Finance
- JANX Health Care
- Exchange
- TBBK Nasdaq
- JANX Nasdaq
- Market Cap
- TBBK 2.6B
- JANX 3.0B
- IPO Year
- TBBK 2004
- JANX 2021
- Fundamental
- Price
- TBBK $55.87
- JANX $40.72
- Analyst Decision
- TBBK Buy
- JANX Strong Buy
- Analyst Count
- TBBK 3
- JANX 11
- Target Price
- TBBK $56.33
- JANX $83.09
- AVG Volume (30 Days)
- TBBK 423.3K
- JANX 1.0M
- Earning Date
- TBBK 01-30-2025
- JANX 03-07-2025
- Dividend Yield
- TBBK N/A
- JANX N/A
- EPS Growth
- TBBK 16.50
- JANX N/A
- EPS
- TBBK 3.95
- JANX N/A
- Revenue
- TBBK $472,068,000.00
- JANX $13,049,000.00
- Revenue This Year
- TBBK N/A
- JANX $40.27
- Revenue Next Year
- TBBK $10.40
- JANX N/A
- P/E Ratio
- TBBK $14.15
- JANX N/A
- Revenue Growth
- TBBK 6.73
- JANX 54.12
- 52 Week Low
- TBBK $29.92
- JANX $7.79
- 52 Week High
- TBBK $61.17
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- TBBK 57.29
- JANX 29.72
- Support Level
- TBBK $54.19
- JANX $40.36
- Resistance Level
- TBBK $56.02
- JANX $47.46
- Average True Range (ATR)
- TBBK 1.67
- JANX 3.76
- MACD
- TBBK 0.43
- JANX -1.57
- Stochastic Oscillator
- TBBK 89.32
- JANX 1.70
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.